Induction of Apoptosis in Human Renal Cell Carcinoma Cells by Vitamin E Succinate in Caspase-independent Manner

Urology

Volumn 73, Issue 1, 2009, Pages 193-199

  Wu, Xiu xian ^a   Kakehi, Yoshiyuki ^a   Jin, Xing hua ^a   Inui, Masashi ^a   Sugimoto, Mikio ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL SUCCINATE; BENZYLOXYCARBONYLVALYLALANYLASPARTYLFLUOROMETHYLKETONE; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CELL STRUCTURE; CELL VIABILITY; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

APOPTOSIS; CARCINOMA, RENAL CELL; CASPASES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; KIDNEY NEOPLASMS; TOCOPHEROLS; TUMOR CELLS, CULTURED; VITAMINS;

EID: 57849121531     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.04.055     Document Type: Article

References (24)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin. 57 (2007) 43-66
2. Amato R.J. Chemotherapy for renal cell carcinoma. Semin Oncol. 27 (2000) 177-186
3. Motzer R.J., Bander N.H., and Nanus D.M. Renal-cell carcinoma. N Engl J Med. 335 (1996) 865-875
4. Hu J., Mao Y., White K., and Canadian Cancer Registries Epidemiology Research Group. Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada. Cancer Causes Cont. 14 (2003) 705-714
5. Prasad K.N., Kumar B., Yan X.D., et al. Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: A review. J Am Coll Nutr. 22 (2003) 108-117
6. Prasad K.N., and Edwards-Prasad J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res. 42 (1982) 550-555
7. Neuzil J., Svensson I., Weber T., et al. Alpha-tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett. 445 (1999) 295-300
8. Yu W., Israel K., Liao Q.Y., et al. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: Role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res. 59 (1999) 953-961
9. Venkateswaran V., Fleshner N.E., and Klotz L.H. Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. J Urol. 168 (2002) 1578-1582
10. Zhang Y., Ni J., Messing E.M., et al. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci USA 99 (2002) 7408-7413
11. Neuzil J., Weber T., Gellert N., et al. Selective cancer cell killing by alpha-tocopheryl succinate. Br J Cancer 84 (2001) 87-89
12. Ripoll E.A., Rama B.N., and Webber M.M. Vitamin E enhances the chemotherapeutic effects of Adriamycin on human prostatic carcinoma cells in vitro. J Urol. 136 (1986) 529-531
13. Weber T., Lu M., Andera L., et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res. 8 (2002) 863-869
14. Tomasetti M., Rippo M.R., Alleva R., et al. Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells. Br J Cancer 90 (2004) 1644-1653
15. Wu X.X., Mizutani Y., Kakehi Y., et al. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells. Cancer Res. 60 (2000) 2912-2918
16. Bhattacharjee H., Carbrey J., Rosen B.P., et al. Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQP9. Biochem Biophys Res Commun. 322 (2004) 836-841
17. Wu X.X., Ogawa O., and Kakehi Y. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by l-buthionine sulfoximine. Int J Oncol. 24 (2000) 1485-1497
18. Wu X.X., Kakehi Y., Mizutani Y., et al. Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil. Int J Oncol. 19 (2001) 19-24
19. Yu W., Sanders B.G., and Kline K. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res. 63 (2003) 2483-2491
20. Kang Y.H., Lee E., Choi M.K., et al. Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate. Int J Cancer 112 (2004) 385-392
21. Ottino P., and Duncan J.R. Effect of alpha-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells. Free Radic Biol Med. 22 (1997) 1145-1151
22. Neuzil J., Wang X.F., Dong L.F., et al. Molecular mechanism of "mitocan"-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett. 580 (2006) 5125-5129
23. Ni J., Chen M., Zhang Y., et al. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochem Biophys Res Commun. 300 (2003) 357-363
24. Roxborough H.E., Burton G.W., and Kelly F.J. Inter- and intra-individual variation in plasma and red blood cell vitamin E after supplementation. Free Radic Res. 33 (2000) 437-445